The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
 
Steven Yip
No Relationships to Disclose
 
Connor Wells
No Relationships to Disclose
 
Raphael Brandao Moreira
No Relationships to Disclose
 
Alex Wong
No Relationships to Disclose
 
Sandy Srinivas
Consulting or Advisory Role - Genentech/Roche; medivation; Novartis; pfizer
Speakers' Bureau - Genentech
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
 
Benoit Beuselinck
No Relationships to Disclose
 
Camillo Porta
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Peloton Therapeutics; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
 
Hao-Wen Sim
No Relationships to Disclose
 
D. Scott Ernst
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Takeshi Yuasa
No Relationships to Disclose
 
Naveen S. Basappa
Honoraria - Astellas Pharma; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Novartis
 
Ravindran Kanesvaran
Honoraria - Astellas Pharma; Janssen; Novartis
Consulting or Advisory Role - Astellas Pharma; Mundipharma; Novartis; pfizer
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Lori Wood
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Christina M. Canil
Honoraria - Astellas Medivation; bayer; Janssen
Consulting or Advisory Role - AstraZeneca; bayer; BMS Brazil; Pfizer; Roche; sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Roche; sanofi
Patents, Royalties, Other Intellectual Property - pfizer
 
Anil Kapoor
No Relationships to Disclose
 
Simon Yuen Fai Fu
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer